Immuneering Corp - Class A Common Stock, par value $0.001 per share (IMRX)

45 filings reported holding IMRX - Immuneering Corp - Class A Common Stock, par value $0.001 per share as of Q1 2025.
Immuneering Corp - Class A Common Stock, par value $0.001 per share (IMRX) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4.5M shares of 64M outstanding shares and own 7.03% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.06M shares), MARSHALL WACE, LLP (808K shares), PRICE T ROWE ASSOCIATES INC /MD/ (659K shares), MORGAN STANLEY (467K shares), BlackRock, Inc. (317K shares), SOUTHPORT MANAGEMENT, L.L.C. (245K shares), GEODE CAPITAL MANAGEMENT, LLC (226K shares), HighTower Advisors, LLC (84K shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (82.7K shares), and STATE STREET CORP (78.5K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.